185.06 USD
--3.40
1.8%
At close Updated Oct 17, 4:00 PM EDT
1 day
-1.8%
5 days
0.82%
1 month
5.62%
3 months
25.99%
6 months
32.83%
Year to date
-12.97%
1 year
-37.32%
5 years
-9.28%
10 years
153.96%
 

About: Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Employees: 39,900

0
Funds holding %
of 7,496 funds
0
Analysts bullish %
of 9 analysts
Positive news %
of articles
Price charts implemented using Lightweight Charts™